BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33224011)

  • 21. The role of the Fanconi anemia network in the response to DNA replication stress.
    Gari K; Constantinou A
    Crit Rev Biochem Mol Biol; 2009; 44(5):292-325. PubMed ID: 19728769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy.
    Badra Fajardo N; Taraviras S; Lygerou Z
    Trends Cancer; 2022 Jun; 8(6):467-481. PubMed ID: 35232683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients.
    Krasnoshtein F; Buchwald M
    Hum Mol Genet; 1996 Jan; 5(1):85-93. PubMed ID: 8789444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in understanding hematopoiesis in Fanconi Anemia.
    Bagby G
    F1000Res; 2018; 7():105. PubMed ID: 29399332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-linked inheritance of Fanconi anemia complementation group B.
    Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H
    Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive role of the Fanconi anemia D2 gene in the replication stress response.
    Tian Y; Shen X; Wang R; Klages-Mundt NL; Lynn EJ; Martin SK; Ye Y; Gao M; Chen J; Schlacher K; Li L
    J Biol Chem; 2017 Dec; 292(49):20184-20195. PubMed ID: 29021208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowered expression levels of a tumor suppressor gene - caveolin-1 within dysregulated gene networks of Fanconi anemia.
    Shyamsunder P; Vidyasekar P; Shukla AR; Mohan S; Verma RS
    Gene; 2013 Sep; 527(2):521-8. PubMed ID: 23845778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High content drug screening for Fanconi anemia therapeutics.
    Montanuy H; Camps-Fajol C; Carreras-Puigvert J; Häggblad M; Lundgren B; Aza-Carmona M; Helleday T; Minguillón J; Surrallés J
    Orphanet J Rare Dis; 2020 Jun; 15(1):170. PubMed ID: 32605631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Multiple Bowen's Disease Skin Lesions by Careful Physical Examination in a Patient With Fanconi Anemia.
    Kawamoto H; Hitaka T; Saito-Sasaki N; Okada E; Sawada Y
    Cureus; 2023 Dec; 15(12):e50016. PubMed ID: 38186461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL17A and IL17RA gene polymorphisms in Fanconi anemia.
    Mobile RZ; Mendes MC; Machado-Souza C; Queiroz PM; Bonfim CMS; Torres-Pereira CC; Schussel JL
    Braz Oral Res; 2023; 37():e012. PubMed ID: 36790253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
    Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
    Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Fanconi anemia by diepoxybutane analysis.
    Auerbach AD
    Curr Protoc Hum Genet; 2015 Apr; 85():8.7.1-8.7.17. PubMed ID: 25827349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fanconi anemia patient with bilaterally hypoplastic scapula and unilateral winging associated with scoliosis and rib abnormality.
    Unal S; Gumruk F
    J Pediatr Hematol Oncol; 2006 Sep; 28(9):616-7. PubMed ID: 17006268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A possible approach for stem cell gene therapy of Fanconi anemia.
    Song L
    Curr Gene Ther; 2009 Feb; 9(1):26-32. PubMed ID: 19275569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fanconi's syndrome (aplastic anemia with multiple malformations)].
    COLETTA S
    Pediatria (Napoli); 1953; 61(3-4):278-82. PubMed ID: 13099873
    [No Abstract]   [Full Text] [Related]  

  • 38. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
    Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
    Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe telomere shortening in Fanconi anemia complementation group L.
    Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
    Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.
    Yung SK; Tilgner K; Ledran MH; Habibollah S; Neganova I; Singhapol C; Saretzki G; Stojkovic M; Armstrong L; Przyborski S; Lako M
    Stem Cells; 2013 May; 31(5):1022-9. PubMed ID: 23280624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.